Cargando…

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity

CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou-Zheng, Lucy, Hatoum-Aslan, Asma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447361/
https://www.ncbi.nlm.nih.gov/pubmed/30942690
http://dx.doi.org/10.7554/eLife.45393
_version_ 1783408492325896192
author Chou-Zheng, Lucy
Hatoum-Aslan, Asma
author_facet Chou-Zheng, Lucy
Hatoum-Aslan, Asma
author_sort Chou-Zheng, Lucy
collection PubMed
description CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a multi-subunit effector complex that destroys invading DNA and RNA. Here, we demonstrate that a model type III system in Staphylococcus epidermidis relies upon the activities of two degradosome-associated nucleases, PNPase and RNase J2, to mount a successful defense. Genetic, molecular, and biochemical analyses reveal that PNPase promotes crRNA maturation, and both nucleases are required for efficient clearance of phage-derived nucleic acids. Furthermore, functional assays show that RNase J2 is essential for immunity against diverse mobile genetic elements originating from plasmid and phage. Altogether, our observations reveal the evolution of a critical collaboration between two nucleic acid degrading machines which ensures cell survival when faced with phage attack.
format Online
Article
Text
id pubmed-6447361
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-64473612019-04-05 A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity Chou-Zheng, Lucy Hatoum-Aslan, Asma eLife Microbiology and Infectious Disease CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a multi-subunit effector complex that destroys invading DNA and RNA. Here, we demonstrate that a model type III system in Staphylococcus epidermidis relies upon the activities of two degradosome-associated nucleases, PNPase and RNase J2, to mount a successful defense. Genetic, molecular, and biochemical analyses reveal that PNPase promotes crRNA maturation, and both nucleases are required for efficient clearance of phage-derived nucleic acids. Furthermore, functional assays show that RNase J2 is essential for immunity against diverse mobile genetic elements originating from plasmid and phage. Altogether, our observations reveal the evolution of a critical collaboration between two nucleic acid degrading machines which ensures cell survival when faced with phage attack. eLife Sciences Publications, Ltd 2019-04-03 /pmc/articles/PMC6447361/ /pubmed/30942690 http://dx.doi.org/10.7554/eLife.45393 Text en © 2019, Chou-Zheng and Hatoum-Aslan http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Microbiology and Infectious Disease
Chou-Zheng, Lucy
Hatoum-Aslan, Asma
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
title A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
title_full A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
title_fullStr A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
title_full_unstemmed A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
title_short A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
title_sort type iii-a crispr-cas system employs degradosome nucleases to ensure robust immunity
topic Microbiology and Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447361/
https://www.ncbi.nlm.nih.gov/pubmed/30942690
http://dx.doi.org/10.7554/eLife.45393
work_keys_str_mv AT chouzhenglucy atypeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity
AT hatoumaslanasma atypeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity
AT chouzhenglucy typeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity
AT hatoumaslanasma typeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity